Skip to main content

Table 1 The baseline characteristics of the patients

From: Biweekly oxaliplatin plus S1 for Chinese elderly patients with advanced gastric or gastroesophageal junction cancer as the first-line therapy: a single-arm, phase 2 study

  No %
Gender
 Male 34 81.0
 Female 8 19.0
Age (years)
 60 ~  < 65 9 21.4
 65 ~  < 70 18 42.9
 70 ~  < 75 11 26.2
  ≥ 75 4 9.5
ECOG
 0 25 59.5
 1 17 40.5
BMI
 Low (< 18.5 kg/m2) 5 11.9
 Normal (18.5 ~  < 24 kg/m2) 22 52.4
 Overweight (24 ~  < 27 kg/m2) 10 23.8
 Obesity (27 ~  < 30 kg/m2) 3 7.1
 Severe obesity (≥ 30 kg/m2) 1 2.4
 Unknown 1 2.4
Disease status
 Recurrent 4 9.5
 Newly diagnosed 38 90.5
HER2 status
 HER2 positive 7 16.7
 HER2 negative 30 71.4
 Unknown 5 11.9
Metastatic site
 Retroperitoneal lymph nodes 25 59.3
 Supraclavicular lymph nodes 16 38.1
 Mediastinal lymph nodes 12 28.6
 Liver 10 23.8
 Peritoneal 10 23.8
 Lung 10 23.8
 Adrenal gland 2 4.8
 Bone 1 2.4
 Ovary 1 2.4
Existing physical illness
 Hypertension 9 21.4
 Diabetes 5 11.9
 Coronary heart disease 5 11.9
 Cerebral infarction 3 7.1
 Carotid artery stenosis 2 4.8
 Arrhythmia 2 4.8
 Liver cirrhosis 1 2.4